Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
47.52 CHF | 0.00% | 0.00% | 0.00% |
07-12 | DOCMORRIS : Hauck & Aufhauser reaffirms its Buy rating | ZD |
07-12 | DOCMORRIS : Deutsche Bank reiterates its Buy rating | ZD |
Sales 2024 * | 1.15B 1.29B 1.76B | Sales 2025 * | 1.52B 1.69B 2.32B | Capitalization | 609M 680M 930M |
---|---|---|---|---|---|
Net income 2024 * | -87M -97.15M -133M | Net income 2025 * | -32M -35.74M -48.84M | EV / Sales 2024 * | 0.74 x |
Net Debt 2024 * | 248M 277M 379M | Net Debt 2025 * | 285M 319M 436M | EV / Sales 2025 * | 0.59 x |
P/E ratio 2024 * |
-6.67
x | P/E ratio 2025 * |
-21.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.72% |
Latest transcript on DocMorris AG
1 day | -47.44% |
Managers | Title | Age | Since |
---|---|---|---|
Walter Hess
CEO | Chief Executive Officer | 59 | 14-12-31 |
Founder | 66 | 93-04-05 | |
Marcel Ziwica
DFI | Director of Finance/CFO | 49 | 00-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 10-03-31 | |
Florian Seubert
BRD | Director/Board Member | 51 | 19-05-22 |
Founder | 66 | 93-04-05 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.19% | 10.1B | |
-46.55% | 8.81B | |
-25.71% | 6.65B | |
-4.16% | 6.45B | |
+97.00% | 5.35B | |
-2.92% | 4.63B | |
+8.08% | 4.6B | |
-32.12% | 3.79B | |
+6.91% | 3.13B |
- Stock Market
- Equities
- ROSE Stock
- ROSE Stock